BiotechTube
Home/NextCure/Solomon Langermann
SL

Solomon Langermann

Senior Vice President, Research & Development

NextCure

Therapeutic Areas

OncologyImmunology

NextCure Pipeline

DrugIndicationPhase
NC318Non-small cell lung cancer (NSCLC), ovarian cancer, other solid tumorsPhase 1/2
NC410Solid tumors (e.g., colorectal, ovarian, pancreatic)Phase 1/2
NC525Acute Myeloid Leukemia (AML)Preclinical

Leadership Team at NextCure

MR
Michael Richman
Former President and Chief Executive Officer
KC
Kevin C. Deenihan
Chief Financial Officer
TM
Timothy Mayer
Chief Operating Officer
LC
Lieping Chen
Co-Founder and Scientific Advisor
ER
Ellen R. Lubman
Chief Business Officer
JJ
James J. Peyer
Board Member
View full NextCure profile